05:05 PM EDT, 04/15/2026 (MT Newswires) -- Marshall Fordyce, Director, President, and CEO, on April 14, 2026, sold 22,951 shares in Vera Therapeutics ( VERA ) for $1,011,051. Following the Form 4 filing with the SEC, Fordyce has control over a total of 457,274 Class A common shares of the company, with 235,244 shares held directly and 222,030 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1831828/000185945326000006/xslF345X05/form4-04152026_080434.xml